Wintrust Financial Corporation »

Cerevel Therapeutics Hldng I shares owned by Wintrust Financial Corporation

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Wintrust Financial Corporation from 13F filings

Historical chart of Wintrust Financial Corporation investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Wintrust Financial Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Wintrust Financial Corporation

Quarter filed Position value Share count Share price at filing
2024-03-31 $14M 333k 42.27

More positions owned by Wintrust Financial Corporation

Microsoft Corp CS (MSFT)
J P Morgan Chase And CS (JPM)
Exxon Mobil Corp CS (XOM)
Merck & Co (MRK)
Disney Walt CS (DIS)
Boston Scientific Corp CS (BSX)
Meta Platforms Inc Cl A CS (META)
Unitedhealth Group CS (UNH)
Blackrock CS (BLK)
Wells Fargo And CS (WFC)
Bank of America Corporation (BAC)
Micron Technology CS (MU)
Broadcom CS (AVGO)
Alphabet Inc Cap Stk Cl A CS (GOOGL)
Berkshire Hathaway (BRK.B)

View all positions for Wintrust Financial Corporation

Top funds holding Cerevel Therapeutics Hldng I

Bain Capital Investors
Perceptive Advisors
venBio Select Advisor
Vanguard Group
BlackRock
Fil
Alpine Associates Management
Paradigm Biocapital Advisors
Pentwater Capital Management
Soros Fund Management
Citigroup
Geode Capital Management
FMR
Baker Bros. Advisors
Millennium Management

View all funds holding Cerevel Therapeutics Hldng I